| |
| |
|
| Insider
Information: |
Boyd Thomas A |
| Relationship: |
Sr. VP, Product Dev. |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
47,137 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$193,262 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
47,137 |
|
|
| Total
Value |
$193,262 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
Sr. VP, Product Dev. |
2010-07-01 |
47,137 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2010-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
47,137 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2010-07-01 |
4 |
D |
$5.35 |
$12,851 |
D/D |
(2,402) |
37,137 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2010-07-01 |
4 |
OE |
$4.44 |
$11,877 |
D/D |
2,675 |
39,539 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2010-06-22 |
4 |
S |
$5.74 |
$13,818 |
D/D |
(2,409) |
36,625 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2010-04-01 |
4 |
D |
$5.36 |
$12,784 |
D/D |
(2,385) |
39,034 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2010-04-01 |
4 |
OE |
$4.56 |
$11,941 |
D/D |
2,621 |
41,419 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2010-01-04 |
4 |
D |
$4.45 |
$12,745 |
D/D |
(2,864) |
38,591 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2010-01-04 |
4 |
OE |
$3.78 |
$11,905 |
D/D |
3,147 |
41,455 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2009-10-01 |
4 |
OE |
$4.26 |
$11,354 |
D/D |
2,666 |
40,486 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2009-10-01 |
4 |
D |
$5.01 |
$12,154 |
D/D |
(2,426) |
38,060 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2009-06-23 |
4 |
AS |
$4.73 |
$9,468 |
D/D |
(2,000) |
36,699 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2009-04-01 |
4 |
OE |
$5.65 |
$11,978 |
D/D |
2,120 |
38,699 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2009-04-01 |
4 |
D |
$6.65 |
$12,828 |
D/D |
(1,929) |
36,579 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2009-01-02 |
4 |
D |
$10.74 |
$13,242 |
D/D |
(1,233) |
38,340 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2009-01-02 |
4 |
OE |
$9.13 |
$12,371 |
D/D |
1,355 |
39,573 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2008-10-01 |
4 |
OE |
$6.53 |
$28,628 |
D/D |
4,384 |
41,098 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2008-10-01 |
4 |
D |
$13.93 |
$41,609 |
D/D |
(2,987) |
38,111 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,667 |
36,205 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2008-07-01 |
4 |
D |
$16.05 |
$42,661 |
D/D |
(2,658) |
29,538 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2008-07-01 |
4 |
OE |
$13.64 |
$39,842 |
D/D |
2,921 |
32,196 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2008-06-23 |
4 |
D |
$17.01 |
$45,914 |
D/D |
(2,700) |
29,205 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2008-04-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,000) |
31,564 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2008-04-01 |
4 |
OE |
$6.52 |
$12,479 |
D/D |
1,914 |
33,647 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2008-04-01 |
4 |
D |
$7.67 |
$13,361 |
D/D |
(1,742) |
31,905 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2008-01-02 |
4 |
D |
$18.03 |
$11,359 |
D/D |
(630) |
36,564 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
